Regulation And Legal
NCLT Adjourns Biomarin vs Sandor Medicaids Hearing
NCLT Hyderabad Bench adjourns Biomarin Pharmaceuticals' Section 9 insolvency petition against Sandor Medicaids to September 2026.
Both parties were represented by counsel during the hybrid mode hearin
